Extensive extra genital Csillag’s disease: a rare case report

Authors

  • Rajesh Rajagopalan Department of Dermatology, KMCH Speciality Hospital, Erode, Tamil Nadu, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20240972

Keywords:

LSA, Extensive, Extra genital

Abstract

Lichen sclerosus et atrophicus (LSA), also called as Csillag’s disease, is characterized by small, shiny, porcelain white, sclerotic papules, plaques and atrophic patches that can occur at any site on the skin including the mucosa. Most commonly found in genitalia, rarely occurring on extragenital skin. Predominantly seen in women with bimodal age distribution. Predominantly an interface dermatoses histopathologically consisting of epidermal atrophy, sclerosis /homogenization of collagen fibers and lichenoid inflammatory infiltrates in dermis. No effective treatment till date although topical steroids, calcineurin inhibitors, topical retinoids and systemic agents like hydroxychloroquine, mexthotrexate, PUVA shows varying inconsistent results. Here we report a case of 36-year-old female having LSA with extensive extra vulval involvement including face. No any other co-existing skin disorders. She showed partial improvement use of physical sunscreens, systemic antimalarials, oral methotrexate and antioxidants.

References

Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol. 1995;32(3):393-416.

Powell JJ, Wojnamwska F. Lichen sclerosus. Lancet. 1999;353(9166):1777-83.

Padmavathy L, Rao L, Dhana Lakshmi, Sylvester N, Ethirajan N. Lichen Sclerosus Atrophicus [LSA] in the Areolae: A Case Report. Case Rep Dermatol Med. 2012;2012:825963.

Kreuter A, Kryvosheyeva Y, Terras S, Moritz R, Möllenhoff K, Altmeyer P, et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients. Acta Derm Venereol. 2013;93(2):238-41.

Arif T, Fatima R, Sami M. Extragenital lichen sclerosus: A comprehensive review. Australas J Dermatol. 2022;63(4):452-62.

Oyama N, Chan I, Neill SM, Hamada T, South AP, Wessagowit V, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet. 2003;362(9378):118-23.

Sherman V, McPherson T, Baldo M, Salim A, Gao XH, Wojnarowska F. The high rate of familial lichen sclerosus suggests a genetic contribution: An observational cohort study. J Eur Acad Dermatol Venereol. 2010;24(9):1031-4.

Guarneri F, Giuffrida R, Di Bari F, Cannavò SP, Benvenga S. Thyroid Autoimmunity and Lichen. Front Endocrinol (Lausanne). 2017;8:146.

Ballester I, Bañuls J, Pérez-Crespo M, Lucas A. Extragenital bullous lichen sclerosus atrophicus. Dermatol Online J. 2009;15(1):6.

Choi SW, Yang JE, Park HJ, Kim CW. A case of extragenital lichen sclerosus following Blaschko's lines. J Am Acad Dermatol. 2000;43(5pt2):903-4.

Smith SD, Fischer G. Childhood onset vulvar lichen sclerosus does not resolve at puberty: A prospective case series. Pediatr Dermatol. 2009;26(6):725-9.

Valdivielso-Ramos M, Bueno C, Hernanz JM. Significant improvement in extensive lichen sclerosus with tacrolimus ointment and PUVA. Am J Clin Dermatol. 2008;9(3):175-9.

Bohm M, Frieling U, Luger TA, Bonsmann G. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol. 2008;9(7):175-9.

Colbert RL, Chiang MP, Carlin CS, Fleming M. Progressive extragenital lichen sclerosus successfully treated with narrowband UV-B phototherapy. Arch Dermatol. 2007;143(1):19-20.

Downloads

Published

2024-04-24

Issue

Section

Case Reports